Drug Information Association Logo
Corporate Tagline

DIA in the News

DIA brings together the world’s leading experts to discuss the most pressing issues related to medical product development. The output from these forums has resulted in the following coverage in a number of highly regarded media outlets.

Benchmark Initiates BioCLinica with Buy, $8 PT as Possible M&A Target

Clinical Trial App Could Save Time On Site Setup VideoClinical Trials Can Waste How Much Money?

Consumer Bodies Unanimously Support Implementation of System

DIA to Organise One-day Workshop on Imaging in Clinical Trials on July 27 in Bengaluru

Drug and Food Safety Trumps Jobs, Say FDA’s Hamburg, Other Regulators 

Drug Information Association Convention Here This Week

Drug Information Association Gathers at Philly Convention Center

Drug Shortages are About Quality but Also About Price

FDA Commissioner: Patient Safety Must be Prioritized Over Job Creation

FierceBiotechIT Lands in Philly for DIA

Life Sciences Key to Philadelphia Future (Op-Ed)

New Mobile Healthcare Survey Reveals Mixed Bag

New Study Sponsored by Medidata Solutions Identifies Up to $5 Billion in Potential Clinical Trial Cost Savings

Nice Insight Looks at Outsourcing Trends from Drug Developer POV

No Differences in Quality of Clinical Trial Data Across Regions, Reports Drug Information Journal

Outsourcing Software for Clinical Trial Management Seeks to Cut Costs

Pharma Giants Seek Temps as Start-up Funding Sags 

Phlexglobal Repositions to Underline Trial Master File Expertise

Research Study Management SaaS Offers Several Integration Tools.

Social Enterprise Compliance Software Manages Compliance Risk

Supreme Court Predictions and Opinions on Disclosing Payments to Doctors

Survey: Future for Mobile Tech in Clinical Trials

Tufts Study Finds Unneeded Trial Data Being Collected

Updates from DIA 2012: “Collaborate to Innovate,” Says the Association